SMTL ID : 7ltx.1 (3 other biounits)

EGFR (T790M/V948R) in complex with quinazolinone allosteric inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.1: 21 residues within 4Å: Chain A: L.27, G.28, S.29, G.30, A.31, G.33, V.35, A.52, K.54, M.99, Q.100, L.101, M.102, C.106, D.146, R.150, N.151, L.153, D.164 Ligands: MG.2, YFA.3 14 PLIP interactions: 14 interactions with chain A Hydrogen bonds: A:A.31, A:Q.100, A:M.102, A:C.106, A:D.146, A:D.146, A:R.150, A:N.151 Water bridges: A:S.29, A:F.32, A:K.54, A:K.54, A:K.54 Salt bridges: A:K.54

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: K.54, N.151, D.164 Ligands: ANP.1 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:D.164, H2O.1, H2O.1

1 x YFA: (2R)-2-{5-fluoro-6-[4-(1-methylpiperidin-4-yl)phenyl]-4-oxoquinazolin-3(4H)-yl}-2-phenyl-N-(1,3-thiazol-2-yl)acetamide(Non-covalent)

YFA.3: 19 residues within 4Å: Chain A: V.35, A.52, I.53, K.54, L.56, A.64, E.67, I.68, E.71, A.72, M.75, C.84, R.85, L.86, L.97, M.99, D.164, F.165 Ligands: ANP.1 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.56, A:I.68, A:I.68, A:E.71, A:E.71, A:L.97 Hydrogen bonds: A:D.164 Salt bridges: A:E.67 pi-Stacking: A:F.165

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gero, T.W. et al., Quinazolinones as allosteric fourth-generation EGFR inhibitors for the treatment of NSCLC. Bioorg.Med.Chem.Lett. (2022)

Release Date

2022-02-23

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence